Showing results (381-390 of 476) with videos related to
Sort By:
Pageof 48
Frontiers in Microbiology|March 13, 2023
Best practice for wildlife gut microbiome research: A comprehensive review of methodology for 16S rRNA gene investigationsLeigh Combrink, Ian R Humphreys, Quinn Washburn, et al.Scientific Reports|April 22, 2020
Bighorn sheep gut microbiomes associate with genetic and spatial structure across a metapopulationClaire E Couch, Holly K Arnold, Rachel S Crowhurst, et al.Journal of the National Cancer Institute. Monographs|November 17, 2005
Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and incomeFeifei Wei, Diana L Miglioretti, Maureen T Connelly, et al.Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000
Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsivenessC M Drysdale, D W McGraw, C B Stack, et al.Pharmacoepidemiology and Drug Safety|September 24, 2005
Frequency of high-risk use of QT-prolonging medicationsNancy M Allen LaPointe, Lesley H Curtis, K Arnold Chan, et al.Epilepsia|July 30, 2024
Uses of antiseizure medication among pregnant women with epilepsy and risk of adverse obstetric outcomes: A group-based trajectory analysisYi-Chin Lin, Chih-Wan Lin, Lin-Chieh Meng, et al.International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 26, 2024
Risks of maternal cardiopulmonary events associated with ritodrine for tocolysis: A national database linkage study in 1 831 564 pregnant womenChih-Wan Lin, K Arnold Chan, Yi-Yung Chen, et al.BMC Pediatrics|November 30, 2005
Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infantsNancy D Lin, Ken Kleinman, K Arnold Chan, et al.Pharmacoepidemiology and Drug Safety|January 25, 2008
Adverse events associated with prolonged antibiotic useSharon B Meropol, K Arnold Chan, Zhen Chen, et al.Pharmacoepidemiology and Drug Safety|August 8, 2006
Risk factors for statin-associated rhabdomyolysisStephanie Schech, David Graham, Judy Staffa, et al.Pageof 48